You are here

kidney disease

Startup targets orphan kidney disease with former Merck drug

MedCity News

Tue, 01/26/21 - 11:10 am

Vera Therapeutics

immunoglobin A nephropathy

Ex-Gilead execs bag $80M to trial drug licensed from Merck KGaA

Fierce Biotech

Tue, 01/19/21 - 10:38 am

Vera Therapeutics

clinical trials

Gilead Sciences

Is It Time For A Race Reckoning In Kidney Medicine?

NPR

Mon, 12/28/20 - 10:38 am

racial disparity

FDA approves Alnylam's first-ever drug for rare kidney disease

Bizjournals

Tue, 11/24/20 - 10:41 am

Primary Hyperoxaluria

Bayer faces an uphill fight with finerenone

EP Vantage

Mon, 10/26/20 - 11:13 am

diabetic kidney disease

clinical trials

Bayer drug shown to slow diabetic kidney disease

NASDAQ

Fri, 10/23/20 - 11:04 am

clinical trials

diabeteic kidney disease

Alnylam makes case for lumasiran in infants ahead of FDA ruling

Fierce Biotech

Fri, 10/23/20 - 10:57 am

Palladio bags $20 million Series B to topple a problematic kidney disease drug

Endpoints

Fri, 09/25/20 - 10:33 am

Palladio Biosciences

autosomal dominant polycystic kidney disease

Alexion Ends Rare Kidney Disease Program Following Poor Data

BioSpace

Fri, 07/31/20 - 11:06 pm

Alexion Pharmaceuticals

Reata Bags $350M As It Preps Rare Chronic Kidney Disease Drug For FDA

Xconomy

Thu, 06/11/20 - 10:42 pm

Reata Pharmaceuticals

chronic kidney disease

bardoxolone methyl

Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia

Xconomy

Thu, 06/11/20 - 10:38 pm

Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech

Xconomy

Tue, 06/2/20 - 11:09 pm

Chinook Therapeutics

Cara and Vifor's Korsuva Hits the Mark for Treating Severe Itching in Kidney Patients

BioSpace

Tue, 04/21/20 - 11:45 pm

Cara Therapeutics

Vifor Fresenius Medical Care Renal Pharma

Bayer’s big kidney disease readout approaches

EP Vantage

Tue, 04/21/20 - 12:27 pm

clinical trials

diabetic kidney disease

Lilly and Boehringer's Jardiance, chasing AZ, nabs speedy FDA review in kidney disease

Fierce Pharma

Thu, 03/12/20 - 10:57 pm

Boehringer Ingelheim

With trial win, Alnylam to seek approval for first treatment of rare kidney disease

Biopharma Dive

Tue, 12/17/19 - 10:29 am

clincial trials

Primary Hyperoxaluria

Roche steers Gazyva into a new PhIII program after combo shows promise in lupus nephritis study

Endpoints

Mon, 11/11/19 - 11:04 am

monoclonal antibodies

clinical trials

Data From 3 Roxadustat Trials Lead Off Kidney Week Sessions Ahead of Efficacy, Safety News

Managed Markets Network

Sat, 11/9/19 - 12:12 pm

EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod

Fierce Pharma

Tue, 09/17/19 - 11:00 am

Boehringer Ingelheim

FDA developing guidance on real-world data quality issues, officials say

Endpoints

Tue, 09/10/19 - 11:34 pm

real world evidence

real world data

Pages